Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Placebo-Controlled Trial of Cipralex in the Treatment of Negative Symptoms in Schizophrenia

NCT00148447 is registered in ClinicalTrials.gov with BeerYaakov Mental Health Center as lead sponsor.

NCT NCT00148447
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00148447 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Placebo-Controlled Trial of Cipralex in the Treatment of Negative Symptoms in Schizophrenia
Lead sponsor
BeerYaakov Mental Health Center
Phase
Phase 3
Overall status
Completed
Start date
November 30, 2004
Completion date
September 30, 2005
Enrollment
40
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

schizophrenia